Two Sigma Investments
BIVV

Two Sigma Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Two Sigma Investments’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-235,300
Closed -$12.7M – 3780
2017
Q4 		$12.7M Buy
+235,300
New +$12.9M 0.04% 512
2017
Q3 		– Sell
-511,413
Closed -$30.8M – 3432
2017
Q2 		$30.8M Sell
511,413
-467,919
-48% -$26.6M 0.11% 232
2017
Q1 		$53.3M Buy
+979,332
New +$48.2M 0.18% 143

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Two Sigma Investments's BIVV Position: Q1 2018 in Review

Two Sigma Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 235,300 shares — an estimated $12.7M sold.

Two Sigma Investments first reported a position in BIVV in Q1 2017 and held it in 3 quarters. The position peaked at $53.3M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Two Sigma Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Two Sigma Investments sold 235,300 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $12.7M.
  • Two Sigma Investments first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 3 quarters.
  • Two Sigma Investments's Bioverativ Inc. Common Stock position peaked at $53.3M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Two Sigma Investments's 13F filing for Q1 2018, filed 15 May 2018.